Garlic!
#garlic
In addition to keeping Vampires away, garlic may be able to ward off bacteria and other disease-causing microorganisms.
A Y 2014 paper published in the Avicenna Journal of Phytomedicine attributed garlic's antimicrobial properties to a compound known as allicin. Garlic may be effective against a wide range of pathogens, including Salmonella, E. coli, Staphylococcus, and candida.
Garlic appears to harm disease-causing microorganisms while leaving the beneficial ones in our gut unharmed. The researchers noted that "garlic has been found to contain a large number of potent bioactive compounds with anticancer properties." It may be able to inhibit the activation of carcinogens, protect DNA from activated carcinogens, and improve the body's ability to detoxify.
Preliminary research suggests that garlic may even be able to help prevent the common cold.
In a study published in Advances in Therapy, researchers gave 146 participants either garlic pills or a placebo and observed for 12 wks. Among those receiving the garlic, there were 24 colds, while the placebo group had 65. The garlic group experienced cold symptoms for only 1.5 days, while those in the placebo group took an average of a little over 5 days to feel better.
Eat healthy, Be healthy, Live lively

Biohacking: The Science of Optimizing Longevity
An evidence-led, optimistic tour of biohacking: what it is, why the science is sound, and how the movement is converging with clinical longevity medicine of the kind practised at Bangkok's Target150.

NK Cells: Powerful Cancer Fighters
Natural killer (NK) cells are the immune system’s first line of defense against cancer. This 2026 guide covers NK cell biology, how they destroy tumors, the latest CAR-NK and memory-like breakthroughs from Dana-Farber, MIT, Yale and McGill, and how to support your own NK cell function.

Larry Fink Called It. CME Just Made It Real. The Compute Futures Market Has Arrived
Bitcoin’s Quiet Surge $BTC
Every story, signed and delivered.
Subscribe to the kxco channel and get the headline, the AI-written key takeaways, and the chain-anchor link the moment we publish. Audio versions and per-ticker subscriptions arrive in the next iteration.

